ALLIANCEBERNSTEIN L.P. - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 94 filers reported holding RECRO PHARMA INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q1 2021$110,000
-2.7%
39,5000.0%0.00%
Q4 2020$113,000
+27.0%
39,500
-7.1%
0.00%
Q3 2020$89,000
-58.4%
42,500
-9.6%
0.00%
Q2 2020$214,000
-11.9%
47,000
+57.7%
0.00%
Q1 2020$243,000
-27.2%
29,800
+63.7%
0.00%
Q4 2019$334,000
+65.3%
18,2000.0%0.00%
Q3 2019$202,000
+0.5%
18,200
-8.1%
0.00%
Q2 2019$201,000
+95.1%
19,800
+13.1%
0.00%
Q1 2019$103,000
-22.6%
17,500
-6.4%
0.00%
Q4 2018$133,0000.0%18,7000.0%0.00%
Q3 2018$133,000
+41.5%
18,7000.0%0.00%
Q2 2018$94,00018,7000.00%
Other shareholders
RECRO PHARMA INC shareholders Q1 2020
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders